Wen-Tsao Ho
Research Subjects
Wen-Tsao Ho has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
Chun-Ying Chen
Ho Wen-Tsao Skin Clinic, Department of Dermatology, New Taipei City, Taiwan
2 shared publicationsShih-Cheng Hsu
Ho Wen-Tsao Skin Clinic, Department of Dermatology, New Taipei City, Taiwan
2 shared publications- An-Hua Jhang
Department of Dermatology, Ho Wen Tsao Skin Clinic, No.179, Sec.2, Wenhua 3rd Rd.,Linkou District, New Taipei City, Taiwan, ROC
1 shared publication Benjamin Xi En Ho
Benjamin Xi En Ho is a student at Asia American International Academy, New Taipei City, Taiwan
1 shared publication- Chi-Hsiang Chiang
Department of Dermatology, Ho Wen Tsao Skin Clinic, No.179, Sec.2, Wenhua 3rd Rd., Linkou District, New Taipei City, Taiwan, ROC
1 shared publication Chin-Yi Yang
Department of Dermatology, New Taipei Municipal TuCheng Hospital, New Taipei City, 236, Taiwan
1 shared publication
Latest Publications
- Open Access
- 1 October 2026
- Published by Our Dermatology Online in Our Dermatology Online
- Vol. 4 (17)
Before vesiculation: Diagnostic safety-netting and hindsight bias in unilateral eczematous eruptions
Before vesiculation: Diagnostic safety-netting and hindsight bias in unilateral eczematous eruptions
- 1 October 2026
- Published by Our Dermatology Online in Our Dermatology Online
- Vol. 4 (17)
Open AccessBefore vesiculation: Diagnostic safety-netting and hindsight bias in unilateral eczematous eruptions
Before vesiculation: Diagnostic safety-netting and hindsight bias in unilateral eczematous eruptions
- 23 September 2026
- Published by Taylor & Francis in Baylor University Medical Center Proceedings
- p. 1
Rosacea and seborrheic dermatitis: association, temporality, and diagnostic overlap
We read with interest the report by Koch et al describing a strong association between recorded diagnoses of rosacea and seborrheic dermatitis (SD) after propensity-score matching: 11.45% of patien...
- 23 September 2026
- Published by Taylor & Francis in Baylor University Medical Center Proceedings
- p. 1
Rosacea and seborrheic dermatitis: association, temporality, and diagnostic overlap
We read with interest the report by Koch et al describing a strong association between recorded diagnoses of rosacea and seborrheic dermatitis (SD) after propensity-score matching: 11.45% of patien...
- Open Access
- 23 September 2026
- Published by PAGEPress Publications in Dermatology Reports
Microbial burden of repackaged versus original-tube clobetasol propionate 0.05% after 7 days of in-use exposure: a pilot study with paired unopened controls
Dear Editor, In Taiwan, dermatology and primary care clinics commonly dispense clobetasol propionate 0.05% cream either in the manufacturer’s original aluminum tube or, more often, by transferring cream from larger factory containers into small plastic boxes at the clinic counter. This long-standing practice reduces drug waste and dispensing costs, but it is performed in a routine consultation environment rather than under laboratory conditions, and the destination boxes are not pre-sterilized. Patients therefore periodically express concern that repackaged creams may be more easily contaminated than original tubes. Empirical data are scarce. We undertook a small comparative pilot study with paired unopened controls (one for each packaging type) to address this concern.
- 23 September 2026
- Published by PAGEPress Publications in Dermatology Reports
Open AccessMicrobial burden of repackaged versus original-tube clobetasol propionate 0.05% after 7 days of in-use exposure: a pilot study with paired unopened controls
Dear Editor, In Taiwan, dermatology and primary care clinics commonly dispense clobetasol propionate 0.05% cream either in the manufacturer’s original aluminum tube or, more often, by transferring cream from larger factory containers into small plastic boxes at the clinic counter. This long-standing practice reduces drug waste and dispensing costs, but it is performed in a routine consultation environment rather than under laboratory conditions, and the destination boxes are not pre-sterilized. Patients therefore periodically express concern that repackaged creams may be more easily contaminated than original tubes. Empirical data are scarce. We undertook a small comparative pilot study with paired unopened controls (one for each packaging type) to address this concern.
- 8 September 2026
- Published by Wiley in International Journal of Dermatology
Food Allergy Testing in Atopic Dermatitis: A Purpose‐First Comparison of International Guidelines
Food allergy testing is frequently requested in atopic dermatitis (AD), yet international guidance appears inconsistent. We performed a structured narrative review of major guidelines, practice parameters, and society statements from North America, Europe, the United Kingdom, and East Asia, current through August 23, 2026. Recommendations were compared by clinical purpose, treatment‐response condition, test modality, and intended consequence. The apparent conflict largely reflects three questions being combined: diagnosis of a suspected immediate immunoglobulin E (IgE)‐mediated reaction, safe introduction of an allergenic food, and investigation of food as a driver of eczema. Across documents, testing is history‐directed and indiscriminate panels are discouraged. For eczema‐trigger investigation, NIAID, NICE, Japanese, and Korean guidance uses a treatment‐response gate; the AAAAI 2022 work group requires optimal skin care before additional testing, while EuroGuiDerm version 4.0 limits testing for suspected food‐triggered eczema to moderate‐to‐severe disease with a supporting history or suspicion. Prevention guidance differs on pre‐introduction peanut screening but agrees on timely introduction. The 2023 Joint Task Force recommendation addresses elimination diets as treatment, not a diagnostic threshold. Positive skin prick testing or food‐specific IgE indicates sensitization, not clinical allergy; automatic elimination may cause nutritional harm and loss of oral tolerance. A purpose‐first pathway reconciles most apparent conflict and supports clinical confirmation before long‐term avoidance. image
- 8 September 2026
- Published by Wiley in International Journal of Dermatology
Food Allergy Testing in Atopic Dermatitis: A Purpose‐First Comparison of International Guidelines
Food allergy testing is frequently requested in atopic dermatitis (AD), yet international guidance appears inconsistent. We performed a structured narrative review of major guidelines, practice parameters, and society statements from North America, Europe, the United Kingdom, and East Asia, current through August 23, 2026. Recommendations were compared by clinical purpose, treatment‐response condition, test modality, and intended consequence. The apparent conflict largely reflects three questions being combined: diagnosis of a suspected immediate immunoglobulin E (IgE)‐mediated reaction, safe introduction of an allergenic food, and investigation of food as a driver of eczema. Across documents, testing is history‐directed and indiscriminate panels are discouraged. For eczema‐trigger investigation, NIAID, NICE, Japanese, and Korean guidance uses a treatment‐response gate; the AAAAI 2022 work group requires optimal skin care before additional testing, while EuroGuiDerm version 4.0 limits testing for suspected food‐triggered eczema to moderate‐to‐severe disease with a supporting history or suspicion. Prevention guidance differs on pre‐introduction peanut screening but agrees on timely introduction. The 2023 Joint Task Force recommendation addresses elimination diets as treatment, not a diagnostic threshold. Positive skin prick testing or food‐specific IgE indicates sensitization, not clinical allergy; automatic elimination may cause nutritional harm and loss of oral tolerance. A purpose‐first pathway reconciles most apparent conflict and supports clinical confirmation before long‐term avoidance. image
- Open Access
- 31 July 2026
- Published by Springer Nature in Cureus
- Vol. 18 (7)
Localization Before Exploration: A Proposed Risk-Stratified Outpatient Framework for Occult Cutaneous Foreign Bodies
Suspected superficial foreign bodies create pressure for immediate removal, although the target may no longer be visible or palpable at examination. In this report, an occult cutaneous foreign body is a suspected object confined to the skin or superficial subcutis that cannot be directly visualized or reliably palpated after initial assessment. Repeated probing in this setting can enlarge the wound, distort tissue planes, and endanger adjacent structures without assuring retrieval. This technical report presents a proposed localization-first outpatient framework for clinically stable patients. It separates retention hazard from exploration hazard, defines a localization threshold before limited intervention, and introduces a pre-agreed procedural stop rule. Radiography is prioritized when radiopaque material is plausible, whereas high-frequency ultrasonography is used for radiolucent material, uncertain depth, or proximity to important structures; a negative ultrasound examination is not treated as definitive exclusion. When immediate intervention is not justified, active observation comprises wound care, tetanus assessment, scheduled reassessment, and explicit return precautions. Once a lesion becomes clinically or sonographically localized, targeted removal may be considered by limited incision, image guidance, or carefully selected punch or elliptical excision. The supporting evidence is a focused narrative synthesis rather than a systematic review, and the two-hazard matrix, localization threshold, follow-up intervals, and stop rule are proposed operational components rather than validated recommendations. No comparative data establish that this framework improves retrieval, safety, or tissue preservation; prospective evaluation is required.
- 31 July 2026
- Published by Springer Nature in Cureus
- Vol. 18 (7)
Open AccessLocalization Before Exploration: A Proposed Risk-Stratified Outpatient Framework for Occult Cutaneous Foreign Bodies
Suspected superficial foreign bodies create pressure for immediate removal, although the target may no longer be visible or palpable at examination. In this report, an occult cutaneous foreign body is a suspected object confined to the skin or superficial subcutis that cannot be directly visualized or reliably palpated after initial assessment. Repeated probing in this setting can enlarge the wound, distort tissue planes, and endanger adjacent structures without assuring retrieval. This technical report presents a proposed localization-first outpatient framework for clinically stable patients. It separates retention hazard from exploration hazard, defines a localization threshold before limited intervention, and introduces a pre-agreed procedural stop rule. Radiography is prioritized when radiopaque material is plausible, whereas high-frequency ultrasonography is used for radiolucent material, uncertain depth, or proximity to important structures; a negative ultrasound examination is not treated as definitive exclusion. When immediate intervention is not justified, active observation comprises wound care, tetanus assessment, scheduled reassessment, and explicit return precautions. Once a lesion becomes clinically or sonographically localized, targeted removal may be considered by limited incision, image guidance, or carefully selected punch or elliptical excision. The supporting evidence is a focused narrative synthesis rather than a systematic review, and the two-hazard matrix, localization threshold, follow-up intervals, and stop rule are proposed operational components rather than validated recommendations. No comparative data establish that this framework improves retrieval, safety, or tissue preservation; prospective evaluation is required.
- Open Access
- 31 January 2026
- Published by Oxford University Press (OUP) in Journal of Surgical Case Reports
- Vol. 2026 (2)
Timing of drainage tube removal and flap recovery after osmidrosis surgery: a case series
The optimal timing for drainage tube removal after osmidrosis surgery is uncertain. This case series investigates the relationship between drainage duration and flap recovery following osmidrosis surgery. Thirty patients (60 axillae) underwent minimally invasive liposuction-assisted curettage combined with the blunt-scissor technique using two 5-mm incisions at the anterior and posterior axillary borders, with one 5-mm Penrose drain inserted per incision. Patients were divided into three groups according to the postoperative day (POD) of drain removal—POD 3, 6, and 9. Tie-over dressings were removed uniformly on POD 3, and white dermal erosions were recorded as indicators of transient ischemia. White erosions occurred in 3, 1, and 0 axillae, respectively, suggesting that maintaining drainage for at least 6 days optimizes flap perfusion and minimizes ischemic dermal changes after osmidrosis surgery.
- 31 January 2026
- Published by Oxford University Press (OUP) in Journal of Surgical Case Reports
- Vol. 2026 (2)
Open AccessTiming of drainage tube removal and flap recovery after osmidrosis surgery: a case series
The optimal timing for drainage tube removal after osmidrosis surgery is uncertain. This case series investigates the relationship between drainage duration and flap recovery following osmidrosis surgery. Thirty patients (60 axillae) underwent minimally invasive liposuction-assisted curettage combined with the blunt-scissor technique using two 5-mm incisions at the anterior and posterior axillary borders, with one 5-mm Penrose drain inserted per incision. Patients were divided into three groups according to the postoperative day (POD) of drain removal—POD 3, 6, and 9. Tie-over dressings were removed uniformly on POD 3, and white dermal erosions were recorded as indicators of transient ischemia. White erosions occurred in 3, 1, and 0 axillae, respectively, suggesting that maintaining drainage for at least 6 days optimizes flap perfusion and minimizes ischemic dermal changes after osmidrosis surgery.
- 22 April 2025
- Published by Wolters Kluwer Health in Annals of Plastic Surgery
- Vol. 95 (3) , 340-341
Overcoming Challenges in Osmidrosis Surgery
- 22 April 2025
- Published by Wolters Kluwer Health in Annals of Plastic Surgery
- Vol. 95 (3) , 340-341
Overcoming Challenges in Osmidrosis Surgery
- 1 April 2025
- Published by Wolters Kluwer Health in Journal of Craniofacial Surgery
- Vol. 36 (7) , 2589
Preconditioning Strategies for Skin Flap Survival: Clinical Observations and Experimental Insights
- 1 April 2025
- Published by Wolters Kluwer Health in Journal of Craniofacial Surgery
- Vol. 36 (7) , 2589
Preconditioning Strategies for Skin Flap Survival: Clinical Observations and Experimental Insights
- Open Access
- 1 January 2025
- Published by Hamad bin Khalifa University Press (HBKU Press) in Qatar Medical Journal
- Vol. 2025 (1) , 2
Intralesional steroid injection for Mondor’s disease: A new approach based on a post-surgical case series
To the Editor, We have carefully reviewed the insightful case report by Avantifiori et al. entitled “Penile Mondor’s disease after open hernia repair surgery: A case report”, which was published in the Qatar Medical Journal.1 Their detailed exploration of penile Mondor’s disease (PMD) following inguinal hernia repair provides valuable perspectives on this rare condition. In light of their work, we wish to present our findings from a series of cases of Mondor’s disease that occurred after axillary osmidrosis surgery. Our experience with this condition and the management strategies we used may contribute to a comparative viewpoint that enhances the broader understanding of Mondor’s disease. Notably, in the present clinical practice, we have applied intralesional steroid injections for treating Mondor’s disease, which has not been previously reported. This treatment strategy is guided by dermatological practices for managing inflammation in conditions such as inflamed cysts or eczema.2-3 Given the efficacy observed in our cases, it may warrant further investigation as a potential therapeutic option.
- 1 January 2025
- Published by Hamad bin Khalifa University Press (HBKU Press) in Qatar Medical Journal
- Vol. 2025 (1) , 2
Open AccessIntralesional steroid injection for Mondor’s disease: A new approach based on a post-surgical case series
To the Editor, We have carefully reviewed the insightful case report by Avantifiori et al. entitled “Penile Mondor’s disease after open hernia repair surgery: A case report”, which was published in the Qatar Medical Journal.1 Their detailed exploration of penile Mondor’s disease (PMD) following inguinal hernia repair provides valuable perspectives on this rare condition. In light of their work, we wish to present our findings from a series of cases of Mondor’s disease that occurred after axillary osmidrosis surgery. Our experience with this condition and the management strategies we used may contribute to a comparative viewpoint that enhances the broader understanding of Mondor’s disease. Notably, in the present clinical practice, we have applied intralesional steroid injections for treating Mondor’s disease, which has not been previously reported. This treatment strategy is guided by dermatological practices for managing inflammation in conditions such as inflamed cysts or eczema.2-3 Given the efficacy observed in our cases, it may warrant further investigation as a potential therapeutic option.